Polyethylene sebacate: Genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system

Journal of Pharmaceutical Sciences

Volumn 98, Issue 12, 2009, Pages 4781-4795

  More, Amol B ^a   Chilgunde, Swapnil N ^b   Kamble, Jyoti C ^b   Patil, Prakash S ^b   Malshe, Vinod C ^c   Vanage, Geeta R ^b   Devarajan, Padma V ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^c Advanced Agro Tech   (India)

Author keywords

Biomaterials; Crystallinity; Extrusion; Genotoxicity; Mutagenicity; Periodontal implants; Polymer synthesis; Polymeric drug delivery system; Roxithromycin; Toxicology

Indexed keywords

AROCLOR 1254; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; MACROGOL 400; POLYETHYLENE DERIVATIVE; POLYETHYLENE SEBACATE; ROXITHROMYCIN; UNCLASSIFIED DRUG;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AMES TEST; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME ABERRATION; COMET ASSAY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DNA DAMAGE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; GEL PERMEATION CHROMATOGRAPHY; GENOTOXICITY; INFRARED SPECTROSCOPY; MALE; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; PERIODONTIC DEVICE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; X RAY DIFFRACTION;

EID: 70449520758     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21796     Document Type: Article

References (33)

1. Vert M, Li SM, Spenlehauer G, Guerin P. 1992. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med 3:432-446.
2. Jain R, Shah NH, Malick AW, Rhodes CT. 1998. Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches. Drug Dev Ind Pharm 24:703-727. (Pubitemid 28346446)
3. Mreguna B, Patrick BD. 1990. Biodegradable polyester polymers as drug carriers. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology, Vol 2. New York: Marcel Dekker, Inc. p. 1-25.
4. Nair LS, Laurencin CT. 2007. Biodegradable polymers as biomaterials. Prog Polym Sci 32:762-798.
5. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. 2004. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1-33. (Pubitemid 38457003)
6. Biogdansky S. 1990. Natural polymers as drug delivery systems. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker Inc. p. 231-259.
7. Jain RA. 2000. The manufacturing techniques of various drug loaded biodegradable poly(lactide-coglycolide) (PLGA) devices. Biomaterials 21:2475-2490.
8. Pillai O, Panchagnula R. 2001. Polymers in drug delivery. Curr Opin Chem Biol 5:447-451.
9. Liu X, Kaminski MD, Chen H, Torno M, Taylor LT, Rosengart AJ. 2007. Synthesis and characterization of highly-magnetic biodegradable poly(D,L-lactide-co-glycolide) nanospheres. J Control Release 119:52-58. (Pubitemid 46561544)
10. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. 1999. Polymeric systems for controlled drug release. Chem Rev 99:3181-3198. (Pubitemid 129583051)
11. Lewis DH. 1990. Controlled release of bioactive agents from lactides/glycolide polymers. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker Inc. p. 1-41.
12. Koyama Y, Ito M, Gokan A, Tanaka K. 1979. Molecular motions in stretched aliphatic polyesters. Am Chem Soc Div Polym Chem Prepr 20:524-526. (Pubitemid 9429554)
13. Shikanov A, Domb A. 2006. Poly(sebacic acid-coricinoleic acid) biodegradable injectable in situ gelling polymer. Biomacromolecules 7:288-296. (Pubitemid 43154505)
14. Dang W, Davlau T, Ylng P, Zhao Y, Nowotmk D, Charles S. 1996. Effects of Gliadel® Wafer initial molecular weight on the erosion of wafer and release of BCNU. J Control Release 42:83-92. (Pubitemid 26297879)
15. Domb J, Rock M, Perkin C, Yipchuck G, Broxup B, Villemure JG. 1995. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials 16:1069-1072.
16. Motlagh D, yang J, Lui K, Webb A, Ameer G. 2006. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 27:4315-4324.
17. Mortensen PB, Gregersen N. 1982. The biological origin of ketotic dicarboxylic aciduria. ii. In vivo and in vitro investigations of the beta-oxidation of C8-C16-dicarboxylic acids in unstarved, starved and diabetic rats. Biochem Biophys Acta - Lipids Lipid Metab 710:477-484.
18. Edlund U, Albertsson AC. 2003. Polyesters based on diacid monomers. Adv Drug Deliv Rev 55:585-609.
19. Malshe VC, Devarajan PV, Shastri SR. 2006. Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof. United States Patent Application 20060286138.
20. Piccolomini R, Di Bonaventura G, Catamo G, Picciani C, Paolantonio M. 1997. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. Oral Microbiol Immunol 12:366-371.
21. OECD, Test Guideline 474: Mammalian erythrocyte micronucleus test, In: OECD Guidelines for Testing of Chemicals, Organization for Economic Cooperation and: Development, Paris, 1997.
22. Chauhan LKS, Pant N, Gupta SK, Srivastava SP. 2000. Induction of chromosome aberrations, micronucleus formation and sperm abnormalities in mouse following carbofuran exposure. Mutat Res 465:123-129.
23. Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF, Shelby M. 1987. Mammalian in vivo cytogenetic assays: Analysis of chromosome aberrations in bone marrow cells. Mutat Res 189:157-165. (Pubitemid 17144429)
24. Singh NP, McCoy MT, Tice RR, Scneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
25. Fluckiger-Isler S, Baumeister M, Braun K, Gervais V, Hasler-Nguyen N, Reimann R, Van Gompel J, Wunderlich H-G, Engelhardt G. 2004. Assessment of the performance of the Ames II™ assay: A collaborative study with 19 coded compound. Mutat Res 558:181-197. (Pubitemid 38229646)
26. Kricheldorf HR, Behnken G, Schwarz G. 2005. Telechelic polyesters of ethane diol and adipic or sebacic acid by means of bismuth carboxylates as non-toxic catalysts. Polymer 46:11219-11224. (Pubitemid 41653315)
27. Schweikl H, Hiller K, Carola B, Kreissl M, Kreismann W, Nusser AN, Steinhauser Wieczorek J, Vasold R, Schmalz G. 2005. Cytotoxic and mutagenic effects of dental composite materials. Biomaterials 26:1713-1719. (Pubitemid 39575314)
28. Thomas AB. 2002. Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated VICRYL Plus antibacterial suture (coated Polyglactin 910 suture with triclosan). Surg Infect 3:45-53.
29. Chauvel-Lebret DJ, Auroy P, Tricot-Doleux S, Bonnaure-Mallet M. 2001. Evaluation of the capacity of the SCGE assay to assess the genotoxicity of biomaterials. Biomaterials 22:1795-1801. (Pubitemid 32564968)
30. ISO (International Organization For Standardization 10993-3) 1982. Test for Genotoxicity, Carcinogenicity and Reproductive Toxicity. Biological Evaluation of Medical Devices, Part 3, 1-7.
31. Yu L. 2001. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev 48:27-42. (Pubitemid 32454482)
32. Hancock BC. 2002. Disordered drug delivery: Destiny, dynamics and Deborah number. J Pharm Pharmacol 54:737-746.
33. Hancock BC, Parks M. 2000. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17:397-404.